Adicet Bio’s (ACET) Buy Rating Reiterated at Guggenheim
Adicet Bio (NASDAQ:ACET – Get Free Report)‘s stock had its “buy” rating restated by analysts at Guggenheim in a report issued on Friday,Benzinga reports. They presently have a $7.00 target price on the stock. A number of other equities analysts have also weighed in on ACET. JMP Securities reiterated a “market perform” rating on shares […]
